3000+ Courses from California Community Colleges

Class Central is learner-supported. When you buy through links on our site, we may earn an affiliate commission.

University of California, Los Angeles

Leiomyosarcoma: Immunotherapy Clinical Trials - UCLA Sarcoma Program

University of California, Los Angeles via YouTube

Start learning Write review

Overview

Explore immunotherapy options for treating leiomyosarcoma in this informative 34-minute video lecture by Dr. Bartosz Chmielowski from the UCLA Sarcoma Program. Gain insights into the differences between immunotherapy and other treatment approaches, understand the basics of the immune system and its responses against cancer, and learn about PDL1 inhibitors like Nivolumab. Discover ongoing clinical trials, compare the effectiveness of immunotherapy in melanoma versus sarcoma, and understand the two different goals of treatment. Delve into the safety aspects of immunotherapy and broaden your knowledge about this innovative approach to cancer treatment.

Syllabus

Introduction
Immunotherapy vs other therapies
What is immunotherapy
Immune system
Immune responses against cancer
PDL1 inhibitors
Nivolumab
Other clinical trials
Melanoma vs sarcoma
Two different goals
Is it safe

Taught by

UCLA Health

Tags

Reviews

Start your review of Leiomyosarcoma: Immunotherapy Clinical Trials - UCLA Sarcoma Program

Start learning

Never Stop Learning.

Get personalized course recommendations, track subjects and courses with reminders, and more.

Sign up for free
Someone learning on their laptop while sitting on the floor.